Concentrix Corp — fact timeline

Bilge Ogut resigned as Director at Concentrix Corp.

“Bilge Ogut resigned from the Board, including any committees thereof, effective immediately.”

Concentrix Corp reported first quarter ended February 28, 2026 results: revenue $2,500.4 million, net income $21.6 million, EPS $0.33. Guidance reaffirmed.

“accompanying financial tables for the reconciliation of each non-GAAP measure to its most directly comparable GAAP measure. First Quarter Fiscal 2026 Highlights: • Revenue of $2,500.4 million, an increase of 5.4% year-on-year on an as reported basis compared to revenue of $2,372.2 million in the prior year first quarter. The Company grew revenue 1.9% year-on-year on a”

Concentrix Corp amended Sixth Amendment to the Receivables Financing Agreement with PNC Bank, National Association valued at up to $750 million (effective 2026-03-20).

“On March 20, 2026, Concentrix Corporation (the “Company”), as servicer, entered into an amendment (the “Amendment”) to its accounts receivable securitization facility (as amended, the “Securitization Facility”) by and among Concentrix Receivables, Inc., a subsidiary of the Company, as borrower, PNC Bank, National Association, as administrative agent, and the group agents and the lenders party thereto.”

Concentrix Corp amended credit facility of up to $750 million with PNC Bank, National Association maturing March 20, 2028.

“The Amendment provides for, among other things, (i) an increase in the commitment of the lenders to provide available borrowings from up to $700 million to up to $750 million and (ii) an extension of the termination date of the Securitization Facility from January 14, 2027 to March 20, 2028.”

Concentrix Corp incurred senior notes of $600,000,000 aggregate principal amount with U.S. Bank Trust Company, National Association at 6.500% per year maturing March 1, 2029.

“On February 24, 2026, Concentrix Corporation (“Concentrix” or the “Company”) issued and sold $600,000,000 aggregate principal amount of its 6.500% Senior Notes due 2029 (the “Notes”).”

Concentrix Corp entered into Fourth Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $600,000,000 aggregate principal amount (effective 2026-02-24).

“On February 24, 2026, Concentrix Corporation (“Concentrix” or the “Company”) issued and sold $600,000,000 aggregate principal amount of its 6.500% Senior Notes due 2029 (the “Notes”).”

Olivier Duha resigned as Director at Concentrix Corp.

“On June 3, 2025, Olivier Duha notified the Board of Directors (the “Board”) of Concentrix Corporation (the “Company”) of his decision to resign from the Board, including any committees thereof, effective immediately.”

Concentrix Corp: Amended bylaws to add procedures and limitations for calling special meetings (effective 2025-03-25).

“In connection with the stockholder approval of the Charter Amendment and effective upon the filing of the Charter Amendment on March 25, 2025, the Board of Directors (the “Board”) of the Company made certain amendments to Article 2, Section 2.3 of the Bylaws (the “Bylaws Amendment”) to provide appropriate procedures for and limitations on the calling of special meetings of stockholders, including:”

Concentrix Corp: Amended certificate of incorporation to permit stockholders with at least 25% ownership to call special meetings (effective 2025-03-25).

“On March 25, 2025, the stockholders of Concentrix Corporation (the “Company” or “Concentrix”) approved an amendment (the “Charter Amendment”) to the Company’s Amended and Restated Certificate of Incorporation, as amended to permit stockholders owning at least 25% of the Company’s common stock (the “Required Ownership”) to call a special meeting of stockholders, subject to certain notice, information, and other requirements set forth in the Company’s Amended and Restated Bylaws, as amended (the “Bylaws”). The Charter Amendment became effective upon filing with the Secretary of State of the State of Delaware on March 25, 2025.”

Concentrix Corp: Amended Article 10 to reduce the supermajority vote requirement for adopting, amending, or repealing bylaws from 66-2/3% to a simple majority (effective 2025-01-09).

“On January 9, 2025, the Board of Directors of Concentrix Corporation (the “Company”) adopted an amendment (the “Amendment”) to the Amended and Restated Bylaws, as amended, of the Company (the “Bylaws”), effective immediately. The Amendment amended Article 10 of the Bylaws to change the supermajority provision that required the vote of at least 66-2/3 percent of the voting power of the shares of the capital stock of the Company to adopt, amend, or repeal the Bylaws to a simple majority.”

Concentrix Corp dismissed KPMG LLP as its auditor.

“On October 28, 2024, the Company notified KPMG that the Company will dismiss KPMG as its independent registered public accounting firm upon completion of the audit of the Company’s consolidated financial statements as of and for the fiscal year ending November 30, 2024”

Concentrix Corp engaged Ernst & Young LLP as its auditor.

“on October 25, 2024, the Audit Committee selected Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm for the Company’s fiscal year ending November 30, 2025”

Concentrix Corp amended credit facility of from up to $500 million to up to $600 million with PNC Bank, National Association at commercial paper rate plus a spread of 0.80% maturing April 24, 2026.

“On April 25, 2024, Concentrix Corporation (the “Company”), as servicer, entered into an amendment (the “Amendment”) to its accounts receivable securitization facility (as amended, the “Securitization Facility”) by and among Concentrix Receivables, Inc., a subsidiary of the Company, as borrower, PNC Bank, National Association, as administrative agent, and the group agents and the lenders party thereto. The Amendment provides for, among other things, an (i) increase in the commitment of the lenders to provide available borrowings from up to $500 million to up to $600 million, (ii) an extension of the termination date of the Securitization Facility from July 5, 2024 to April 24, 2026, and (iii) an amendment to the interest rate margins”

Concentrix Corp amended Third Amendment to the Receivables Financing Agreement with Concentrix Receivables, Inc., PNC Bank, National Association valued at up to $600 million (effective 2024-04-25).

“On April 25, 2024, Concentrix Corporation (the “Company”), as servicer, entered into an amendment (the “Amendment”) to its accounts receivable securitization facility (as amended, the “Securitization Facility”) by and among Concentrix Receivables, Inc., a subsidiary of the Company, as borrower, PNC Bank, National Association, as administrative agent, and the group agents and the lenders party thereto.”

Concentrix Corp reported the fiscal first quarter ended February 29, 2024 results: revenue $ 2,402.7, net income $ 52.1, EPS $ 0.76. Guidance reaffirmed.

“technology, today announced financial results for the fiscal first quarter ended February 29, 2024. Three Months Ended February 29, 2024 February 28, 2023 Change Revenue ($M) $ 2,402.7 $ 1,636.4 46.8 % Operating income ($M) $ 148.4 $ 156.0 (4.9) % Non-GAAP operating income ($M) (1) $ 319.1 $ 217.6 46.6 % Operating margin 6.2 % 9.5 % -330 bps Non-GAAP operating”

Concentrix Corp shareholders approved Advisory approval of the compensation of the Company's named executive officers at the 2024-03-21 meeting.

“3. The approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's proxy statement. For Against Abstain Broker Non-Votes 53,478,237 3,693,302 85,250 1,793,442”

Concentrix Corp shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered accounting firm for fiscal year 2024 at the 2024-03-21 meeting.

“2. The ratification of the appointment of KPMG LLP as the Company's independent registered accounting firm for fiscal year 2024. For Against Abstain Broker Non-Votes 58,943,126 33,400 73,705 —”

Concentrix Corp shareholders approved Election of ten directors to serve on the Company's Board of Directors for terms expiring at the 2025 Annual Meeting at the 2024-03-21 meeting.

“Nominee For Withhold Broker Non-Votes Christopher Caldwell 56,628,797 627,992 1,793,442 Teh-Chien Chou 56,500,103 756,686 1,793,442 LaVerne Council 55,564,821 1,691,968 1,793,442 Jennifer Deason 56,718,181 538,608 1,793,442 Olivier Duha 53,623,700 3,633,089 1,793,442 Nicolas Gheysens 55,251,213 2,005,576 1,793,442 Kathryn Hayley 56,508,925 747,864 1,793,442 Kathryn Marinello 55,728,347 1,528,442 1,793,442 Dennis Polk 52,015,947 5,240,842 1,793,442 Ann Vezina 55,182,412 2,074,377 1,793,442”

Concentrix Corp reported financial results for the quarter and year ended November 30, 2023.

“Concentrix Corporation (the “Company” or “Concentrix”) issued a press release reporting its financial results for the quarter and year ended November 30, 2023.”

Rick Rosso changed role as other at Concentrix Corp.

“Mr. Rosso will continue with the Company and transition into a non-executive officer leadership role with the Company for an unspecified period of time prior to his retirement.”

Craig Gibson was appointed as Executive Vice President, Global Sales and Account Management at Concentrix Corp.

“On January 4, 2024, the Board of Directors of Concentrix Corporation (the “Company”) appointed Craig Gibson to the role of Executive Vice President, Global Sales and Account Management, effective immediately.”

Concentrix Corp reported third quarter ended August 31, 2023 results: revenue $1,632.8 million, net income $77.6 million, EPS $1.49.

“accompanying financial tables for the reconciliation of each non-GAAP measure to its most directly comparable GAAP measure. Third Quarter Fiscal 2023 Highlights: • Revenue was $1,632.8 million, up 3.4% from the prior year third quarter, including a de minimis impact of foreign exchange rates compared with the prior year period, compared with $1,579.6 million in the”

Concentrix Corp completed an acquisition involving Sellers (holders of shares of Marnix Lux SA) for approximately €488.7 million in cash (the "Closing Cash Payment") and the Sellers' Note (as defined and described below) (the Sellers' Note together with the Cl (closed 2023-09-25).

“on the Closing Date, except as otherwise set forth in the SPA, (i) Purchaser purchased certain of the Sellers’ Shares (the “Acquired Shares”) in exchange for approximately €488.7 million in cash (the “Closing Cash Payment”) and the Sellers’ Note (as defined and described below) (the Sellers’ Note together with the Closing Cash Payment, the “Cash Purchase Price”);”

Concentrix Corp incurred loan of €700,000,000 with certain Sellers at two percent (2%) per annum maturing September 25, 2025.

“Concentrix issued a promissory note in the aggregate principal amount of €700,000,000 (the “Sellers’ Note”) to certain Sellers (each, a “Noteholder”).”

Concentrix Corp entered into Sellers' Note with certain Sellers valued at €700,000,000 (effective 2023-09-25).

“On the Closing Date and as part of the consideration for the Transaction, Concentrix issued a promissory note in the aggregate principal amount of €700,000,000 (the “Sellers’ Note”) to certain Sellers”

Nicolas Gheysens was appointed as Director at Concentrix Corp.

“Effective as of the closing of the Transaction, on September 25, 2023, Olivier Duha and Nicolas Gheysens were appointed as members of the Company’s Board of Directors”

Olivier Duha was appointed as Director at Concentrix Corp.

“Effective as of the closing of the Transaction, on September 25, 2023, Olivier Duha and Nicolas Gheysens were appointed as members of the Company’s Board of Directors”

Concentrix Corp shareholders voted on Adjournment of the Special Meeting at the 2023-08-04 meeting.

“2. The approval of the adjournment of the Special Meeting to a later date, if necessary or appropriate, including to solicit additional proxies. For Against Abstain Broker Non-Votes 41,177,192 5,246,321 112,095 —”

Concentrix Corp shareholders approved Approval of the issuance of shares in exchange for capital stock at the 2023-08-04 meeting.

“On August 4, 2023, Concentrix Corporation (the “Company” or “Concentrix”) held a special meeting of stockholders (the “Special Meeting”) for which the Company’s Board of Directors solicited proxies pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended. At the Special Meeting, the Company’s stockholders (1) approved the issuance of 15,611,885 shares of the Company’s common stock in exchange for certain shares of the capital stock of Marnix Lux SA, and (2) approved the adjournment of the Special Meeting to a later date, if necessary or appropriate, including to solicit additional proxies. Set forth below are the final voting results for these proposals, each of which were described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on July 6, 2023: 1. The approval of the issuance of 15,611,885 shares of the Company’s common stock in exchange for certain shares of the capital stock of Marnix Lux SA. For Against Abstain”

Concentrix Corp incurred senior notes of $800,000,000 aggregate principal amount of 6.650% Senior Notes due 2026, $800,000,000 aggregate principal amount of 6.60 with U.S. Bank Trust Company, National Association at 6.650% per annum for the 2026 Notes, 6.600% per annum for the 2028 Notes and 6.8 maturing 2026, 2028 and 2033, respectively.

“On August 2, 2023, Concentrix Corporation (“Concentrix” or the “Company”) issued and sold (i) $800,000,000 aggregate principal amount of 6.650% Senior Notes due 2026 (the “2026 Notes”), (ii) $800,000,000 aggregate principal amount of 6.600% Senior Notes due 2028 (the “2028 Notes”) and (iii) $550,000,000 aggregate principal amount of 6.850% Senior Notes due 2033 (the “2033 Notes” and, together with the 2026 Notes and 2028 Notes, the “Notes,” and such offering, the “Notes Offering”).”

Concentrix Corp entered into Indenture with U.S. Bank Trust Company, National Association valued at $800,000,000 aggregate principal amount of 6.650% Senior Notes due 2026, $800,000,000 aggregate prin (effective 2023-08-02).

“On August 2, 2023, Concentrix Corporation (“Concentrix” or the “Company”) issued and sold (i) $800,000,000 aggregate principal amount of 6.650% Senior Notes due 2026 (the “2026 Notes”), (ii) $800,000,000 aggregate principal amount of 6.600% Senior Notes due 2028 (the “2028 Notes”) and (iii) $550,000,000 aggregate principal amount of 6.850% Senior Notes due 2033 (the “2033 Notes” and, together with the 2026 Notes and 2028 Notes, the “Notes,” and such offering, the “Notes Offering”).”

Concentrix Corp reported second quarter ended May 31, 2023 results: revenue $1,614.7 million, net income $78.9 million, EPS $1.51.

“accompanying financial tables for the reconciliation of each non-GAAP measure to its most directly comparable GAAP measure. Second Quarter Fiscal 2023 Highlights: • Revenue was $1,614.7 million, up 3.0% from the prior year second quarter, including a 1.6-point negative impact of foreign exchange rates compared with the prior year period, compared with $1,568.1 million”

Concentrix Corp amended Amendment Agreement with JPMorgan Chase Bank, N.A. and Bank of America, N.A. valued at $1.0425 billion and approximately $2.1447 billion (effective 2023-04-21).

“On April 21, 2023, Concentrix entered into an Amendment and Restatement Agreement (the “Amendment Agreement”) with the lenders party thereto, JPMorgan Chase Bank, N.A. and Bank of America, N.A. to amend and restate Concentrix’ Credit Agreement dated as of October 16, 2020 (as so amended and restated, the “Restated Credit Agreement”).”

Concentrix Corp entered into Put Option and Share Purchase and Contribution Agreement with OSYRIS S.à r.l., Marnix Lux SA stockholders valued at €500 million cash + €700 million note + 14,861,885 shares + up to 750,000 earnout shares (effective 2023-03-29).

“On March 29, 2023, Concentrix and OSYRIS S.à r.l., a private limited liability company ( société à responsabilité limitée ) incorporated under the laws of the Grand Duchy of Luxembourg and a direct wholly owned subsidiary of the Company (“Purchaser”), entered into a binding put option letter agreement (the “Put Option”) with certain stockholders (the “Beneficiaries”) of Marnix Lux SA, a public limited liability company ( société anonyme ) incorporated under the laws of the Grand Duchy of Luxembourg (“Webhelp Parent”) and the parent company of the Webhelp business.”

Concentrix Corp reported financial results for the fiscal first quarter ended February 28, 2023.

“On March 29, 2023, Concentrix Corporation (the “Company” or “Concentrix”) issued a press release reporting its financial results for the first quarter ended February 28, 2023.”

Concentrix Corp shareholders approved Advisory approval of the compensation of the Company's named executive officers. at the 2023-03-23 meeting.

“3. The approval, on an advisory basis, of the compensation of the Company’s named executive officers, as described in the Company’s proxy statement. For Against Abstain Broker Non-Votes 39,467,699 6,109,335 46,563 1,625,946”

Concentrix Corp shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for fiscal year 2023. at the 2023-03-23 meeting.

“2. The ratification of the appointment of KPMG LLP as the Company’s independent registered accounting firm for fiscal year 2023. For Against Abstain Broker Non-Votes 47,125,469 35,863 88,211 —”

Concentrix Corp shareholders approved Election of eight directors to serve on the Board of Directors for terms expiring at the 2024 Annual Meeting of Stockholders. at the 2023-03-23 meeting.

“1. The election of eight directors to serve on the Company’s Board of Directors for terms expiring at the Company’s 2023 Annual Meeting of Stockholders. Nominee For Withhold Broker Non-Votes Christopher Caldwell 45,327,832 295,765 1,625,946 Teh-Chien Chou 44,089,289 1,534,308 1,625,946 LaVerne Council 45,094,575 529,022 1,625,946 Jennifer Deason 43,748,415 1,875,182 1,625,946 Kathryn Hayley 44,598,087 1,025,510 1,625,946 Kathryn Marinello 45,218,433 405,164 1,625,946 Dennis Polk 43,527,699 2,095,898 1,625,946 Ann Vezina 44,966,300 657,297 1,625,946”

Concentrix Corp reported financial results for the fiscal fourth quarter and fiscal year ended November 30, 2022.

“On January 19, 2023, Concentrix Corporation (the “Company” or “Concentrix”) issued a press release reporting its financial results for the quarter and year ended November 30, 2022.”

Jane C. Fogarty was appointed as Executive Vice President, Legal and Corporate Secretary at Concentrix Corp.

“Jane C. Fogarty has succeeded Mr. Richie as Executive Vice President, Legal and Corporate Secretary of the Company.”

Steven L. Richie departed as Executive Vice President, Legal and Corporate Secretary at Concentrix Corp.

“Mr. Richie departed the Company on October 29, 2021.”

Steven L. Richie departed as Executive Vice President, Legal and Corporate Secretary at Concentrix Corp.

“On July 20, 2021, Steven L. Richie, Executive Vice President, Legal and Corporate Secretary of Concentrix Corporation (the “Company” or “Concentrix”) announced his intention to step down from his position at the Company in the fourth fiscal quarter of 2021.”